三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

未开盘 03-09 16:08:19

20.440

-1.160

-5.37%

最高20.920	最低19.740	成交量4,573万
今开20.820	昨收21.600	日振幅5.46%
总市值518.77亿	流通市值518.77亿	总股本25.38亿
成交额9.28亿	换手率1.80%	流通股本25.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":20.44,"timestamp":1773043699003,"preClose":21.6,"halted":0,"volume":45728522,"delay":0,"changeRate":-0.053703703703703705,"floatShares":2538000000,"shares":2538000000,"eps":0.85,"marketStatus":"未开盘","change":-1.16,"latestTime":"03-09 16:08:19","open":20.82,"high":20.92,"low":19.74,"amount":928368806,"amplitude":0.05463,"askPrice":20.44,"askSize":89000,"bidPrice":20.42,"bidSize":15500,"shortable":3,"etf":0,"ttmEps":1.050735,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":21.6,"dividendRate":0.012231,"openAndCloseTimeList":[[1773019800000,1773028800000],[1773032400000,1773043200000]],"volumeRatio":1.5459563024408036,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2618649157","title":"每日卖空追踪 | 三生制药 03月09日卖空量成交96.8万股，卖空比例为2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618649157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618649157?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045022,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月09日，跌5.37%，卖空量成交96.8万股，较上一交易日减少52.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163245a45ae680&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163245a45ae680&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","BK1161","HK0000165453.HKD","BK1583"],"gpt_icon":0},{"id":"2617819146","title":"每日卖空追踪 | 三生制药 03月06日卖空量成交158.35万股，卖空比例为3.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617819146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617819146?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785822,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月06日，涨9.42%，卖空量成交158.35万股，较上一交易日减少2.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","01530","BK1161","BK1593","BK1583"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势，三生制药 涨9.83%，基石药业-B涨6.84%，荣昌生物涨6.31%，映恩生物-B涨5.98%，四环医药涨5.76%，恒瑞医药涨5.77%，君圣泰医药-B涨5.58%，康诺亚-B涨5.31%，复宏汉霖涨5.02%。交银国际表示，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU2328871848.SGD","BK1583","09606","01276","00460","HK0000252160.HKD","HK0000165453.HKD","BK1515","HK0000320223.HKD","LU0359201612.USD","LU1023057109.AUD","BK1593","HK0000320264.USD","LU1969619763.USD","LU0359202008.SGD","02616","BK1587","BK1600","BK1574","06978","09995","LU2543165471.USD","LU0359201885.HKD","02696","BK1191","159992","HK0000500386.USD","02162","HK0000306685.HKD","HK0000306701.USD","BK1161","HK0000252152.HKD","02511"],"gpt_icon":0},{"id":"2617184681","title":"三生制药盘中异动 早盘急速拉升5.07%报20.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617184681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617184681?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:43","pubTimestamp":1772761432,"startTime":"0","endTime":"0","summary":"2026年03月06日早盘09时43分，三生制药股票出现波动，股价快速拉升5.07%。截至发稿，该股报20.740港元/股，成交量659.81万股，换手率0.26%，振幅6.69%。资金方面，该股资金流入7450.45万港元，流出2932.11万港元。三生制药股票所在的药品行业中，整体涨幅为0.18%。其相关个股中，和黄医药、劲方医药-B、三生制药涨幅较大，振幅较大的相关个股有和黄医药、三生制药、英硅智能，振幅分别为7.03%、6.48%、6.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306094352a6a8d0b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306094352a6a8d0b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583","HK0000165453.HKD"],"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","02228","LU2399975544.HKD","BK1574","LU2778985437.USD","IE00BPRC5H50.USD","BK1585","09939","IE00B5MMRT66.SGD","LU1719994722.HKD","SG9999004311.SGD","01099","03329","02196","LU1961090484.USD","BK1197","LU0640798160.USD","LU2476274308.USD","BK1593","LU1794554557.SGD","03933","BK1191","LU2328871848.SGD","LU0348827113.USD","LU0348825331.USD","BK1207","LU0561508036.HKD","SG9999014674.SGD","09926","LU2476274720.SGD","02268","LU0588546209.SGD","BK1515","09688","BK1141","LU0348766576.USD","LU1115378108.SGD","LU0348784397.USD","06160","01789","02367","LU0348735423.USD","LU0348783233.USD","LU0540923850.HKD","01530","LU2488822045.USD","159938","LU1770034418.SGD","LU0417516571.SGD","LU1303224171.USD"],"gpt_icon":0},{"id":"2616104537","title":"每日卖空追踪 | 三生制药 03月04日卖空量成交54.8万股，卖空比例为2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616104537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616104537?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613022,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月04日，跌3.53%，卖空量成交54.8万股，较上一交易日减少69.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163250a44a6bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163250a44a6bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1161","BK1583","BK1593","01530"],"gpt_icon":0},{"id":"2616191537","title":"三生制药盘中异动 临近午盘股价大跌5.00%报19.360港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616191537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616191537?lang=zh_cn&edition=full","pubTime":"2026-03-04 11:34","pubTimestamp":1772595288,"startTime":"0","endTime":"0","summary":"2026年03月04日临近午盘11时34分，三生制药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报19.360港元/股，成交量1062.66万股，换手率0.42%，振幅5.50%。资金方面，该股资金流入7906.12万港元，流出1.02693亿港元。最近的财报数据显示，该股实现营业收入47.76亿港元，净利润14.89亿港元，每股收益0.63港元，毛利40.75亿港元，市盈率21.77倍。三生制药股票所在的药品行业中，整体跌幅为0.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113448a44958e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113448a44958e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","01530","BK1583","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"1153034423","title":"三生制药（01530）2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1153034423","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153034423?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:36","pubTimestamp":1772527001,"startTime":"0","endTime":"0","summary":"三生制药（01530）于2026年3月3日发布2026年2月股份变动月报表。公告显示，截至2026年2月28日，公司注册股本维持不变，数量为50,000,000,000股，面值每股0.00001美元，注册股本总额仍为50万美元。期末已发行股份总数为2,538,005,412股，与月初持平，期间无新增发行、回购或注销行为，亦无库存股变化。\n根据公告，公司已确认符合适用的公众持股量要求。期内无股份期权、权证或可换股票据等事项变动。公告由公司秘书黎少娟签署，确认遵守香港联交所《上市规则》及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538865?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","09926","BK1100","BK1197","BK1617","LU0348735423.USD","LU2488822045.USD","LU0307460666.USD","BK1583","LU0640798160.USD","LU2328871848.SGD","06978","BK1141","LU0634319403.HKD","HK0000165453.HKD","06160","IE00B543WZ88.USD","01099","SG9999014674.SGD","LU0348784397.USD","LU1303224171.USD","02196","02268","LU1794554557.SGD","09688","02228","LU0348827113.USD","LU2399975544.HKD","01789","SG9999004311.SGD","BK1161","LU0561508036.HKD","159992","BK1515","IE00BPRC5H50.USD","LU1961090484.USD","LU1720050803.USD","03933","BK1585","LU0348783233.USD","01530","BK1574","LU2476274720.SGD","LU0588546209.SGD","LU0348825331.USD","LU1969619763.USD","02367","BK1207","LU1115378108.SGD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2616712807","title":"瑞银：料医疗健康板块收入今年续增长10% 改列三生制药(01530)为首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2616712807","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616712807?lang=zh_cn&edition=full","pubTime":"2026-03-02 13:46","pubTimestamp":1772430360,"startTime":"0","endTime":"0","summary":"瑞银改列三生制药为首选股，取代翰森制药，给予三生制药“买入”评级及目标价41港元，认为其估值合理。展望2026年，该行预测板块收入增长中位数为10%，看好创新药销售增长稳健及研发进展理想。该行并上调多只股份目标价，将石药集团目标价由10港元上调至10.9港元，翰森制药目标价由48.2港元上调至51.5港元，恒瑞医药目标价从96.9港元升至98.3港元，并分别给予“中性”、“买入”及“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1960683339.HKD","LABU","LU0326950275.SGD","LU1226287529.USD","LU1226288253.USD","LU2039709279.SGD","LU0501845795.SGD","LU0140636845.USD","BK1589","IE00BZ08YS42.EUR","LU1226287792.SGD","XBI","IE00B5MMRT66.SGD","01276","LU0359201612.USD","03692","LU1813983027.USD","BK4581","BK4588","HK0000165453.HKD","LU1023057109.AUD","LU0314109678.HKD","LU1152091168.USD","BK1521","IE00B031HY20.USD","IE0008369823.USD","IE00BZ08YR35.GBP","XLV","LU1328277881.USD","LU0880133367.SGD","LU1152091754.HKD","BK1161","IE00BZ08YT58.USD","BK1593","IE00B543WZ88.USD","LU2543165471.USD","LU0315179316.USD","LU1951186391.HKD","01530","SG9999004220.SGD","BK1583","BK4585","LU0359201885.HKD","159760","IE0008368742.USD","LU1226287875.USD","01093","LU0072913022.USD","BK1515"],"gpt_icon":0},{"id":"2616827182","title":"医药生物行业周报：GSK联手中国新锐 SIRNA赛道布局再下一城","url":"https://stock-news.laohu8.com/highlight/detail?id=2616827182","media":"开源证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616827182?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"GSK 携手前沿生物加速布局siRNA，中国企业研发实力正获国际认可GSK 重点合作布局小核酸，已具有多款重磅管线。据Insight 统计，自2009 年起，GSK 已进行多起小核酸相关BD 交易，其中较多集中于ASO 和siRNA 领域。siRNA 领域，GSK 延续早期ASO 所布局的乙肝类管线协同性，与Arrowhead、WAVE 等企业在肝脏相关疾病领域着力布局。本周医药生物上涨0.5%，跑输沪深300 指数0.58pct，在31 个子行业中排名第25 位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","03759","HK0000165453.HKD","BK1583","BK1161","01530","02359"],"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009267?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU0348767384.USD","SG9999014674.SGD","LU2476274308.USD","BK1141","LU0540923850.HKD","09926","LU0640798160.USD","02367","BK1207","LU0348766576.USD","01530","01789","03933","LU1794554557.SGD","IE00B543WZ88.USD","LU0634319403.HKD","BK1191","LU0417516738.SGD","LU2399975544.HKD","BK1588","HK0000165453.HKD","BK1515","LU2476274720.SGD","03329","LU0348784397.USD","09688","BK1617","BK1161","09939","LU0348827113.USD","LU0588546209.SGD","IE00BPRC5H50.USD","LU1720050803.USD","BK1147","01099","02196","06160","LU0348825331.USD","159938","LU2488822045.USD","LU1961090484.USD","LU1251922891.USD","BK1100","02228","BK1197","LU1770034418.SGD","LU0417516571.SGD","LU0417516902.SGD","02268"],"gpt_icon":0},{"id":"2614039315","title":"每日卖空追踪 | 三生制药 02月25日卖空量成交83.85万股，卖空比例为6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614039315?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008224,"startTime":"0","endTime":"0","summary":"三生制药北京时间02月25日，涨1.08%，卖空量成交83.85万股，较上一交易日减少68.38%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163251a71d590f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163251a71d590f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1583","BK1593","HK0000165453.HKD"],"gpt_icon":0},{"id":"2614039327","title":"三生制药02月25日主力净流入2323.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039327","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614039327?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007357,"startTime":"0","endTime":"0","summary":"02月25日, 三生制药股价涨1.08%，报收22.54元，成交金额3.0亿元，换手率0.53%，振幅2.51%，量比1.38。三生制药今日主力资金净流入2323.6万元，上一交易日主力净流出1315.0万元。该股近5个交易日下跌3.50%，主力资金累计净流入3589.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4728.4万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162108a71d4bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162108a71d4bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1161","HK0000165453.HKD","BK1593"],"gpt_icon":0},{"id":"2613475340","title":"65款国产1类新药有望今年上市！涉恒瑞、悦康、以岭、科伦...","url":"https://stock-news.laohu8.com/highlight/detail?id=2613475340","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613475340?lang=zh_cn&edition=full","pubTime":"2026-02-23 18:59","pubTimestamp":1771844347,"startTime":"0","endTime":"0","summary":"据不完全统计，恒瑞医药的SHR4640片、悦康药业的紫花温肺止嗽颗粒、以岭药业的芪桂络痹通片、三生制药的重组红细胞生成刺激蛋白注射液......65款国产1类新药有望于今年内获批上市。恒瑞至少有5款1类新药有望于2026年获批上市，涉及消化系统、免疫疾病、肌肉-骨骼、妇科等治疗领域。目前，悦康药业已有3款中药1类新药报产在审、上市可期。芪桂络痹通片已于2025年3月申报NDA获受理，有望于今年3月底传来喜讯。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223191152a715bfc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223191152a715bfc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1593","BK1583","HK0000165453.HKD"],"gpt_icon":0},{"id":"2613534797","title":"每日卖空追踪 | 三生制药 02月23日卖空量成交77.3万股，卖空比例为18.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613534797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613534797?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835422,"startTime":"0","endTime":"0","summary":"三生制药北京时间02月23日，股价较前一交易日持平，卖空量成交77.3万股，较上一交易日减少53.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163245a71563b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163245a71563b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000165453.HKD","BK1593","01530","BK1583"],"gpt_icon":0},{"id":"2613753415","title":"三生制药02月23日获主力加仓1506.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753415","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613753415?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:16","pubTimestamp":1771834564,"startTime":"0","endTime":"0","summary":"02月23日，三生制药股价收平报23.90元，成交金额9917.6万元，换手率0.16%，振幅3.01%，量比0.46。三生制药今日主力资金净流入1506.4万元，上一交易日主力净流入1558.8万元。该股近5个交易日下跌0.91%，主力资金累计净流入2245.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.1亿元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162131a4be7540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162131a4be7540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","HK0000165453.HKD","BK1161","01530","BK1593"],"gpt_icon":0},{"id":"2612792265","title":"每日卖空追踪 | 三生制药 02月20日卖空量成交61.9万股，卖空比例为10.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612792265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612792265?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576221,"startTime":"0","endTime":"0","summary":"三生制药北京时间02月20日，涨1.19%，卖空量成交61.9万股，较上一交易日增加293.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163237a4b5e7a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163237a4b5e7a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583","HK0000165453.HKD"],"gpt_icon":0},{"id":"2612265743","title":"三生制药02月20日主力净流入1558.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2612265743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612265743?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575336,"startTime":"0","endTime":"0","summary":"02月20日, 三生制药股价涨1.19%，报收23.90元，成交金额1.4亿元，换手率0.24%，振幅3.81%，量比0.46。三生制药今日主力资金净流入1558.8万元，上一交易日主力净流出484.7万元。该股近5个交易日下跌1.80%，主力资金累计净流出338.9万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.3亿元，其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161722a4b5dc1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161722a4b5dc1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1593","BK1161","01530","BK1583"],"gpt_icon":0},{"id":"2612252506","title":"IO2.0争夺战打响，下一代肿瘤“药王”花落谁家？","url":"https://stock-news.laohu8.com/highlight/detail?id=2612252506","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612252506?lang=zh_cn&edition=full","pubTime":"2026-02-20 15:00","pubTimestamp":1771570819,"startTime":"0","endTime":"0","summary":"下一代肿瘤“药王”争夺战打响！撰文丨粽哥2025下一代肿瘤“药王”，极有可能诞生于PD-1+X领域。以K药为代表的PD-1单抗，开启了一代IO治疗时代，但却存在耐药和冷肿瘤缺乏应答的问题。临床上，T细胞耗竭现象是导致免疫检查点获得性耐药的关键机制。TIGIT是经典免疫逃逸靶点，在多种淋巴细胞上表达，被认为是“下一个PD-1”。不过，PD-1/TIGIT双抗或有望打破TIGIT“难以成药”的魔咒。TIGIT和PD-1表达之间存在很强的相关性，特别是在肺癌的肿瘤浸","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","01530","BK1161","LU2476274720.SGD","LU2778985437.USD","LU0348735423.USD","LU1720050803.USD","LU0348827113.USD","02898","IE00B543WZ88.USD","LU0348784397.USD","09887","LU0417516738.SGD","LU2399975544.HKD","LU0348783233.USD","LU0348766576.USD","09995","LU0417516902.SGD","LU2488822045.USD","LU0348825331.USD","01801","IE00B5MMRT66.SGD","LU0634319403.HKD","BK1574","02616","LU0561508036.HKD","LU2476274308.USD","LU0540923850.HKD","LU1961090484.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU1794554557.SGD","09926","LU0417516571.SGD","01877","01177"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.109},{"period":"3month","weight":-0.2736},{"period":"6month","weight":-0.3787},{"period":"1year","weight":1.7217},{"period":"ytd","weight":-0.1547}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.00666},{"month":2,"riseRate":0.454545,"avgChangeRate":0.00178},{"month":3,"riseRate":0.727273,"avgChangeRate":0.104098},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045323}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}